Gurit Holding AG
SIX:GURN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Gurit Holding AG
SIX:GURN
|
CH |
|
Futura Medical PLC
LSE:FUM
|
UK |
|
N
|
NovaBay Pharmaceuticals Inc
XBER:B9P
|
US |
|
A
|
Arion Entertainment Singapore Ltd
SGX:YYB
|
SG |
|
B
|
Brook Crompton Holdings Ltd
SGX:AWC
|
SG |
|
M
|
Man Industries India Ltd
NSE:MANINDS
|
IN |
|
10X Genomics Inc
NASDAQ:TXG
|
US |
|
W
|
Wee Hur Holdings Ltd
SGX:E3B
|
SG |
|
N
|
Nike Inc
XETRA:NKE
|
US |
|
F
|
Ferrum SA
WSE:FER
|
PL |
|
Garb Oil & Power Corp
OTC:GARB
|
US |
|
Harris Technology Group Ltd
ASX:HT8
|
AU |
|
Yunnan Metropolitan Real Estate Development Co Ltd
SSE:600239
|
CN |
|
Sultan Resources Ltd
ASX:SLZ
|
AU |
|
MPC Muenchmeyer Petersen Capital AG
XETRA:MPCK
|
DE |
|
Entegris Inc
NASDAQ:ENTG
|
US |
|
Dongwon Industries Co Ltd
KRX:006040
|
KR |
|
Iervolino & Lady Bacardi Entertainment SpA
MIL:IE
|
IT |
|
A
|
ACS Actividades de Construccion y Servicios SA
VSE:ACS
|
ES |
|
D
|
Dar Global PLC
LSE:DAR
|
UK |
|
Maxigen Biotech Inc
TWSE:1783
|
TW |
|
Filtronic PLC
LSE:FTC
|
UK |
|
R
|
Refrigeration Electrical Engineering Corp
VN:REE
|
VN |
|
PayGroup Ltd
ASX:PYG
|
AU |
Cash Flow Statement
Cash Flow Statement
Gurit Holding AG
| Jun-2021 | Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | Jun-2024 | Dec-2024 | Jun-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||
| Net Income |
35
|
9
|
15
|
9
|
(3)
|
4
|
(0)
|
(28)
|
(96)
|
(60)
|
|
| Depreciation & Amortization |
13
|
13
|
14
|
15
|
15
|
15
|
15
|
15
|
13
|
12
|
|
| Stock-Based Compensation |
0
|
2
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
|
| Other Non-Cash Items |
8
|
21
|
(12)
|
(7)
|
16
|
10
|
9
|
31
|
96
|
76
|
|
| Cash Taxes Paid |
16
|
14
|
10
|
8
|
6
|
4
|
5
|
7
|
8
|
8
|
|
| Change in Working Capital |
8
|
(22)
|
(29)
|
(1)
|
13
|
9
|
7
|
(5)
|
(15)
|
(8)
|
|
| Cash from Operating Activities |
64
N/A
|
21
-67%
|
(11)
N/A
|
16
N/A
|
42
+157%
|
38
-10%
|
30
-19%
|
13
-56%
|
(2)
N/A
|
20
N/A
|
|
| Investing Cash Flow | |||||||||||
| Capital Expenditures |
(29)
|
(24)
|
(16)
|
(15)
|
(15)
|
(11)
|
(11)
|
(11)
|
(8)
|
(9)
|
|
| Other Items |
1
|
1
|
(8)
|
(6)
|
2
|
(3)
|
(13)
|
(13)
|
(3)
|
(0)
|
|
| Cash from Investing Activities |
(27)
N/A
|
(23)
+15%
|
(23)
+1%
|
(21)
+9%
|
(12)
+41%
|
(14)
-11%
|
(24)
-75%
|
(24)
+2%
|
(12)
+51%
|
(9)
+22%
|
|
| Financing Cash Flow | |||||||||||
| Net Issuance of Common Stock |
(3)
|
(3)
|
(2)
|
(2)
|
0
|
0
|
(0)
|
(1)
|
(0)
|
(0)
|
|
| Net Issuance of Debt |
(34)
|
1
|
35
|
13
|
(45)
|
(37)
|
0
|
16
|
13
|
5
|
|
| Cash Paid for Dividends |
(14)
|
(14)
|
(3)
|
(3)
|
0
|
0
|
(2)
|
(2)
|
0
|
0
|
|
| Other |
(0)
|
1
|
1
|
(3)
|
0
|
(4)
|
0
|
0
|
0
|
0
|
|
| Cash from Financing Activities |
(52)
N/A
|
(16)
+69%
|
31
N/A
|
5
-85%
|
(48)
N/A
|
(37)
+23%
|
(2)
+95%
|
14
N/A
|
13
-9%
|
4
-65%
|
|
| Change in Cash | |||||||||||
| Effect of Foreign Exchange Rates |
1
|
0
|
(1)
|
(2)
|
(2)
|
(2)
|
(1)
|
0
|
(1)
|
(2)
|
|
| Net Change in Cash |
(14)
N/A
|
(18)
-30%
|
(5)
+70%
|
(2)
+66%
|
(20)
-998%
|
(15)
+27%
|
4
N/A
|
4
+4%
|
(2)
N/A
|
13
N/A
|
|
| Free Cash Flow | |||||||||||
| Free Cash Flow |
35
N/A
|
(3)
N/A
|
(27)
-821%
|
1
N/A
|
27
+3 213%
|
27
-2%
|
20
-26%
|
3
-85%
|
(10)
N/A
|
11
N/A
|
|